From: The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study
Concordance index (confidence interval)
Cohort (n)
NICE
CPG
PCBaSe (72,337)
0.77 (0.76–0.77)
0.81 (0.81–0.82)
Singapore (2550)
0.76 (0.73–0.80)
0.79 (0.76–0.83)